LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
LCII
LCI Industries
LCII has the edge over LCID overall, supported by lower modeled downside and stronger valuation.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
LCII Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Stable | |
| Healthy |
LCII's profitability and balance sheet are currently healthy, and its cash flow is stable, but its revenue is under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
LCII PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.6x | $78.22 | -19% |
| Current | 12x | $96.99 | — |
| Fair | 16x | $132 | +36% |
| Expensive | 26x | $212 | +119% |
Historical ranges are pointers, not guarantees.
LCII's PE is in its cheap range at 12x.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
LCII Forward outlook
There aren't enough analyst estimates for LCII to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
LCII Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $8.12 | +14% |
| Q2 2026 | $8.62 | +44% |
| Q1 2026 | $8.16 | +34% |
| Q4 2025 | $7.57 | +35% |
| Q3 2025 | $7.15 | +39% |
| Q2 2025 | $5.99 | +26% |
| Q1 2025 | $6.10 | +66% |
| Q4 2024 | $5.60 | +122% |
LCII has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over LCII on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
LCII Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $992.5M | -4.2% |
| Q2 2026 | $968.7M | -13% |
| Q1 2026 | $1.1B | +4.3% |
| Q4 2025 | $932.7M | +16% |
| Q3 2025 | $1B | +13% |
| Q2 2025 | $1.1B | +5% |
| Q1 2025 | $1B | +8% |
| Q4 2024 | $803.1M | -4.1% |
LCII's revenue fell from its 2022 peak and has held roughly level since: $992M last quarter, down 4.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.6% | +0.3 points |
| Q2 2026 | 9.9% | +2 points |
| Q1 2026 | 8.7% | +1 points |
| Q4 2025 | 3.8% | +1.8 points |
| Q3 2025 | 7.3% | +1.4 points |
| Q2 2025 | 7.9% | -0.7 points |
| Q1 2025 | 7.8% | +1.8 points |
| Q4 2024 | 2% | +1.7 points |
LCII has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
LCII Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $53.6M | -34% |
| Q2 2026 | $184.9M | +86% |
| Q1 2026 | -$43.1M | -228% |
| Q4 2025 | $64.3M | -33% |
| Q3 2025 | $80.9M | +18% |
| Q2 2025 | $99.5M | -45% |
| Q1 2025 | $33.7M | +$49.9M |
| Q4 2024 | $95.7M | -24% |
LCII has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LCII Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 1.8x | Healthy |
| Q3 2025 | 2.0x | Healthy |
| Q2 2025 | 2.1x | Moderate |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 1.7x | Healthy |
LCII's net debt is about 1.4 years of its operating earnings (EBITDA), down from 2.0 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
LCII Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.6 | Neutral |
| Stochastic | 63.9 | Neutral |
LCII's weekly RSI is 49 (neutral) and its Stochastic is 64 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
LCII PE vs Consumer Cyclical Sector
| Metric | LCII | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 34% below |
| PE % | 23 | 47 | 24 pts below |
LCII is trading at 12x earnings, a 34% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
LCII Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.5 | 9.6% above |
| 20 week MA | $96.3 | 0.7% above |
| 50 week MA | $112.3 | 14% below |
| 100 week MA | $104.4 | 7.1% below |
| 200 week MA | $109.8 | 12% below |
LCII has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
LCII Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $108.7 | $134.3 | +24% |
| 2021 | $134.3 | $149.9 | +12% |
| 2022 | $149.9 | $94.8 | -37% |
| 2023 | $94.8 | $125.7 | +33% |
| 2024 | $125.7 | $102.7 | -18% |
| 2025 | $102.7 | $123.7 | +20% |
| 2026 YTD | $123.7 | $97.0 | -22% |
LCII has the edge over LCID on returns for 2026, with the stronger performance.